BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 33836250)

  • 1. Jolkinolide B targets thioredoxin and glutathione systems to induce ROS-mediated paraptosis and apoptosis in bladder cancer cells.
    Sang J; Li W; Diao HJ; Fan RZ; Huang JL; Gan L; Zou MF; Tang GH; Yin S
    Cancer Lett; 2021 Jul; 509():13-25. PubMed ID: 33836250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Curcuminoid B63 induces ROS-mediated paraptosis-like cell death by targeting TrxR1 in gastric cells.
    Chen X; Chen X; Zhang X; Wang L; Cao P; Rajamanickam V; Wu C; Zhou H; Cai Y; Liang G; Wang Y
    Redox Biol; 2019 Feb; 21():101061. PubMed ID: 30590310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Jolkinolide B synergistically potentiates the antitumor activity of GPX4 inhibitors via inhibiting TrxR1 in cisplatin-resistant bladder cancer cells.
    Sang J; Liu CK; Liu J; Luo GC; Zheng WJ; Bai Y; Jiang DY; Pu JN; An S; Xu TR
    Biochem Pharmacol; 2024 May; 223():116194. PubMed ID: 38583812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potent inhibition of gastric cancer cells by a natural compound via inhibiting TrxR1 activity and activating ROS-mediated p38 MAPK pathway.
    He W; Cao P; Xia Y; Hong L; Zhang T; Shen X; Zheng P; Shen H; Zhao Y; Zou P
    Free Radic Res; 2019 Jan; 53(1):104-114. PubMed ID: 30668191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Withaferin A, a natural thioredoxin reductase 1 (TrxR1) inhibitor, synergistically enhances the antitumor efficacy of sorafenib through ROS-mediated ER stress and DNA damage in hepatocellular carcinoma cells.
    Chen X; Zhu N; Wu Y; Zhang Y; Zhang Y; Jin K; Zhou Z; Chen G; Wang J
    Phytomedicine; 2024 Jun; 128():155317. PubMed ID: 38537439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective killing of gastric cancer cells by a small molecule via targeting TrxR1 and ROS-mediated ER stress activation.
    Chen W; Zou P; Zhao Z; Weng Q; Chen X; Ying S; Ye Q; Wang Z; Ji J; Liang G
    Oncotarget; 2016 Mar; 7(13):16593-609. PubMed ID: 26919094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Curcumin potentiates antitumor activity of cisplatin in bladder cancer cell lines via ROS-mediated activation of ERK1/2.
    Park BH; Lim JE; Jeon HG; Seo SI; Lee HM; Choi HY; Jeon SS; Jeong BC
    Oncotarget; 2016 Sep; 7(39):63870-63886. PubMed ID: 27564099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Jolkinolide B sensitizes bladder cancer to mTOR inhibitors via dual inhibition of Akt signaling and autophagy.
    Sang J; Gan L; Zou MF; Lin ZJ; Fan RZ; Huang JL; Li W; Tang GH; Yin S
    Cancer Lett; 2022 Feb; 526():352-362. PubMed ID: 34798195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Costunolide specifically binds and inhibits thioredoxin reductase 1 to induce apoptosis in colon cancer.
    Zhuge W; Chen R; Vladimir K; Dong X; Zia K; Sun X; Dai X; Bao M; Shen X; Liang G
    Cancer Lett; 2018 Jan; 412():46-58. PubMed ID: 29037867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Curcuminoid WZ26, a TrxR1 inhibitor, effectively inhibits colon cancer cell growth and enhances cisplatin-induced cell death through the induction of ROS.
    Zhang T; Zheng P; Shen X; Shao R; Wang B; Shen H; Zhang J; Xia Y; Zou P
    Free Radic Biol Med; 2019 Sep; 141():93-102. PubMed ID: 31176737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Celastrol acts synergistically with afatinib to suppress non-small cell lung cancer cell proliferation by inducing paraptosis.
    Dai CH; Zhu LR; Wang Y; Tang XP; Du YJ; Chen YC; Li J
    J Cell Physiol; 2021 Jun; 236(6):4538-4554. PubMed ID: 33230821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement of auranofin-induced lung cancer cell apoptosis by selenocystine, a natural inhibitor of TrxR1 in vitro and in vivo.
    Fan C; Zheng W; Fu X; Li X; Wong YS; Chen T
    Cell Death Dis; 2014 Apr; 5(4):e1191. PubMed ID: 24763048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EF24 induces ROS-mediated apoptosis via targeting thioredoxin reductase 1 in gastric cancer cells.
    Zou P; Xia Y; Chen W; Chen X; Ying S; Feng Z; Chen T; Ye Q; Wang Z; Qiu C; Yang S; Liang G
    Oncotarget; 2016 Apr; 7(14):18050-64. PubMed ID: 26919110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The mode of cisplatin-induced cell death in CYP2E1-overexpressing HepG2 cells: modulation by ERK, ROS, glutathione, and thioredoxin.
    Lu Y; Cederbaum A
    Free Radic Biol Med; 2007 Oct; 43(7):1061-75. PubMed ID: 17761302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alantolactone promotes ER stress-mediated apoptosis by inhibition of TrxR1 in triple-negative breast cancer cell lines and in a mouse model.
    Yin C; Dai X; Huang X; Zhu W; Chen X; Zhou Q; Wang C; Zhao C; Zou P; Liang G; Rajamanickam V; Wang O; Zhang X; Cui R
    J Cell Mol Med; 2019 Mar; 23(3):2194-2206. PubMed ID: 30609207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Curcuminoid WZ35 synergize with cisplatin by inducing ROS production and inhibiting TrxR1 activity in gastric cancer cells.
    He W; Xia Y; Cao P; Hong L; Zhang T; Shen X; Zheng P; Shen H; Liang G; Zou P
    J Exp Clin Cancer Res; 2019 May; 38(1):207. PubMed ID: 31113439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acetyl-macrocalin B suppresses tumor growth in esophageal squamous cell carcinoma and exhibits synergistic anti-cancer effects with the Chk1/2 inhibitor AZD7762.
    Wang JN; Che Y; Yuan ZY; Lu ZL; Li Y; Zhang ZR; Li N; Li RD; Wan J; Sun HD; Sun N; Puno PT; He J
    Toxicol Appl Pharmacol; 2019 Feb; 365():71-83. PubMed ID: 30633885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Costunolide induces apoptosis in platinum-resistant human ovarian cancer cells by generating reactive oxygen species.
    Yang YI; Kim JH; Lee KT; Choi JH
    Gynecol Oncol; 2011 Dec; 123(3):588-96. PubMed ID: 21945308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nitrovin (difurazone), an antibacterial growth promoter, induces ROS-mediated paraptosis-like cell death by targeting thioredoxin reductase 1 (TrxR1).
    Zhao L; Zhong B; Zhu Y; Zheng H; Wang X; Hou Y; Lu JJ; Ai N; Guo X; Ge W; Ma YY; Chen X
    Biochem Pharmacol; 2023 Apr; 210():115487. PubMed ID: 36893814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phospho-ibuprofen (MDC-917) suppresses breast cancer growth: an effect controlled by the thioredoxin system.
    Sun Y; Rowehl LM; Huang L; Mackenzie GG; Vrankova K; Komninou D; Rigas B
    Breast Cancer Res; 2012 Jan; 14(1):R20. PubMed ID: 22293394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.